vs
STANDARD BIOTOOLS INC.（LAB）与WILLAMETTE VALLEY VINEYARDS INC（WVVI）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是WILLAMETTE VALLEY VINEYARDS INC的1.8倍（$19.6M vs $11.1M），WILLAMETTE VALLEY VINEYARDS INC净利率更高（7.3% vs -177.4%，领先184.7%），WILLAMETTE VALLEY VINEYARDS INC同比增速更快（-1.5% vs -11.5%），WILLAMETTE VALLEY VINEYARDS INC自由现金流更多（$-532.1K vs $-23.1M），过去两年WILLAMETTE VALLEY VINEYARDS INC的营收复合增速更高（12.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
威拉米特谷酒庄是一家位于美国俄勒冈州特纳市的葡萄酒酿造企业，得名于俄勒冈州的威拉米特谷，是俄勒冈州规模领先的威拉米特谷法定产区黑皮诺葡萄酒生产商，同时出产霞多丽、灰皮诺葡萄酒，2016年时是威拉米特谷最大的雷司令葡萄酒生产商。
LAB vs WVVI — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $11.1M |
| 净利润 | $-34.7M | $811.0K |
| 毛利率 | 48.5% | 58.6% |
| 营业利润率 | -168.5% | 2.2% |
| 净利率 | -177.4% | 7.3% |
| 营收同比 | -11.5% | -1.5% |
| 净利润同比 | -28.8% | 65.2% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $11.1M | ||
| Q3 25 | $19.6M | $8.4M | ||
| Q2 25 | $21.8M | $10.2M | ||
| Q1 25 | $40.8M | $7.5M | ||
| Q4 24 | — | $11.3M | ||
| Q3 24 | $22.1M | $9.4M | ||
| Q2 24 | $22.5M | $10.3M | ||
| Q1 24 | $45.5M | $8.8M |
| Q4 25 | — | $811.0K | ||
| Q3 25 | $-34.7M | $-1.1M | ||
| Q2 25 | $-33.5M | $92.8K | ||
| Q1 25 | $-26.0M | $-729.0K | ||
| Q4 24 | — | $490.9K | ||
| Q3 24 | $-26.9M | $-282.9K | ||
| Q2 24 | $-45.7M | $196.0K | ||
| Q1 24 | $-32.2M | $-521.8K |
| Q4 25 | — | 58.6% | ||
| Q3 25 | 48.5% | 59.9% | ||
| Q2 25 | 48.8% | 61.0% | ||
| Q1 25 | 48.4% | 63.1% | ||
| Q4 24 | — | 58.9% | ||
| Q3 24 | 54.9% | 62.0% | ||
| Q2 24 | 46.1% | 62.6% | ||
| Q1 24 | 53.1% | 59.9% |
| Q4 25 | — | 2.2% | ||
| Q3 25 | -168.5% | -14.5% | ||
| Q2 25 | -118.1% | 3.9% | ||
| Q1 25 | -80.8% | -11.5% | ||
| Q4 24 | — | 6.9% | ||
| Q3 24 | -120.9% | -1.5% | ||
| Q2 24 | -134.5% | 5.2% | ||
| Q1 24 | -132.2% | -6.8% |
| Q4 25 | — | 7.3% | ||
| Q3 25 | -177.4% | -13.1% | ||
| Q2 25 | -153.7% | 0.9% | ||
| Q1 25 | -63.8% | -9.7% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | -122.0% | -3.0% | ||
| Q2 24 | -203.3% | 1.9% | ||
| Q1 24 | -70.6% | -5.9% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $410.9K |
| 总债务越低越好 | — | $14.0M |
| 股东权益账面价值 | $399.7M | $66.2M |
| 总资产 | $539.6M | $107.7M |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
| Q4 25 | — | $410.9K | ||
| Q3 25 | $129.4M | $372.6K | ||
| Q2 25 | $158.6M | $350.6K | ||
| Q1 25 | $150.9M | $332.9K | ||
| Q4 24 | — | $320.9K | ||
| Q3 24 | $210.6M | $303.2K | ||
| Q2 24 | $269.8M | $279.8K | ||
| Q1 24 | $287.1M | $256.5K |
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $12.9M | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $66.2M | ||
| Q3 25 | $399.7M | $67.6M | ||
| Q2 25 | $424.5M | $68.6M | ||
| Q1 25 | $454.6M | $68.5M | ||
| Q4 24 | — | $69.2M | ||
| Q3 24 | $489.3M | $71.0M | ||
| Q2 24 | $510.3M | $71.3M | ||
| Q1 24 | $577.3M | $71.1M |
| Q4 25 | — | $107.7M | ||
| Q3 25 | $539.6M | $107.6M | ||
| Q2 25 | $557.0M | $106.6M | ||
| Q1 25 | $579.6M | $108.2M | ||
| Q4 24 | — | $109.0M | ||
| Q3 24 | $681.5M | $107.3M | ||
| Q2 24 | $708.7M | $106.5M | ||
| Q1 24 | $777.7M | $106.2M |
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $-344.5K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-532.1K |
| 自由现金流率自由现金流/营收 | -118.1% | -4.8% |
| 资本支出强度资本支出/营收 | 4.5% | 1.7% |
| 现金转化率经营现金流/净利润 | — | -0.42× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $-2.2M |
8季度趋势，按日历期对齐
| Q4 25 | — | $-344.5K | ||
| Q3 25 | $-22.2M | $-1.4M | ||
| Q2 25 | $-20.7M | $1.3M | ||
| Q1 25 | $-30.3M | $-1.3M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | $-27.9M | $52.2K | ||
| Q2 24 | $-39.0M | $800.7K | ||
| Q1 24 | $-62.5M | $-3.0M |
| Q4 25 | — | $-532.1K | ||
| Q3 25 | $-23.1M | $-1.5M | ||
| Q2 25 | $-22.6M | $1.2M | ||
| Q1 25 | $-35.3M | $-1.4M | ||
| Q4 24 | — | $-1.4M | ||
| Q3 24 | $-30.1M | $-373.9K | ||
| Q2 24 | $-41.0M | $45.8K | ||
| Q1 24 | $-63.3M | $-3.3M |
| Q4 25 | — | -4.8% | ||
| Q3 25 | -118.1% | -18.1% | ||
| Q2 25 | -103.6% | 12.2% | ||
| Q1 25 | -86.6% | -19.0% | ||
| Q4 24 | — | -12.8% | ||
| Q3 24 | -136.4% | -4.0% | ||
| Q2 24 | -182.2% | 0.4% | ||
| Q1 24 | -138.9% | -37.7% |
| Q4 25 | — | 1.7% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 0.7% | ||
| Q1 25 | 12.4% | 1.3% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | 10.2% | 4.5% | ||
| Q2 24 | 8.6% | 7.3% | ||
| Q1 24 | 1.7% | 3.5% |
| Q4 25 | — | -0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 14.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 4.09× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
WVVI
| Direct Sales | $5.8M | 52% |
| Distributor Sales | $5.3M | 48% |
